Showing 228 results

Filters Content type: News, Editors' picks, About HIV Topic: Neurological & cognitive problems

Cognitive changes, memory loss, dementia, peripheral neuropathy, stroke and other neurological issues.

Drug interactions & pharmacokinetics

Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

Editor's pick
Infectious Disease Advisor
11 June 2018
Child developmental issues

Children born with HIV on treatment experience next-to-no developmental set-backs at the age of 5

Editor's pick
AVERT
25 May 2018
Neurological & cognitive problems

Early HIV treatment key to avoiding brain atrophy

Editor's pick
Eurekalert Medicine & Health
4 May 2018
Neurological & cognitive problems

Study Suggests That Understanding Chronic Pain Can Help Patients Manage It Better

Editor's pick
The Body Pro
22 March 2018
Neurological & cognitive problems

HIV and Neurocognitive Disorders: Looking for Drugs that Decrease Inflammation

Editor's pick
Pharmacy Times
13 March 2018
Neurological & cognitive problems

Marijuana may help HIV patients keep mental stamina longer

Editor's pick
Michigan State University
7 February 2018
Neurological & cognitive problems

HIV does not increase aging-related brain changes in patients on ART

Editor's pick
Healio
16 January 2018
Neurological & cognitive problems

Middle-aged HIV-positive people have increased risk of 'silent' cerebral vascular disease linked to more severe health problems

News
2 January 2018
Neurological & cognitive problems

No change in cognitive function or brain structure in people taking effective HIV treatment for 2 years

News
13 November 2017
Neurological & cognitive problems

Cognitive Impairment Risk Rises With Increasing Age of People With HIV

Editor's pick
Poz
20 October 2017
Treatment guidelines

Chronic pain common in people living with HIV

Editor's pick
EurekAlert
14 September 2017
Mental & emotional health problems

Case reports of severe dolutegravir-related depression

News
5 September 2017
Side effects

Few people with HIV starting raltegravir and dolutegravir change therapy because of side-effects

News
21 July 2017
Cardiovascular disease

People treated with atazanavir had lower risk of stroke and heart attack

News
18 July 2017
Neurological & cognitive problems

Is there HIV in my brain? Neurologist Dr. Joanna Hellmuth fills us in

Editor's pick
BETA blog
21 June 2017
Neurological & cognitive problems

Researchers say rule out depression, anxiety, unemployment and other stresses before blaming cognitive impairment for everyday difficulties

News
19 June 2017
Neurological & cognitive problems

Risk score can identify which HIV-positive people with controlled viral load are at greatest risk of neurocognitive decline

News
16 June 2017
Neurological & cognitive problems

Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study

News
10 May 2017
Ageing & HIV

Studies look at brain and cognitive changes in people with HIV as they age

News
14 March 2017
Neurological & cognitive problems

Well-Treated HIV Is Still Associated With Vascular Abnormalities in the Brain

Editor's pick
Poz
28 February 2017
Neurological & cognitive problems

No evidence of accelerated brain ageing in HIV positive people on effective ART

Editor's pick
HIV i-Base
19 February 2017
Neurological & cognitive problems

Link found between HIV treatment, neuronal degeneration

Editor's pick
Science Daily
19 December 2016
Side effects

Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

News
25 October 2016
Adherence

Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation

News
12 October 2016